跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LYRICA CR pregabalin 330mg modified release tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
LYRICA CR pregabalin 330mg modified release tablet bottle
Approved
STANDARD
LYRICA CR pregabalin 330mg modified release tablet bottle
Viatris Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0f7264923f6cb5d6
Company
Viatris Pty Ltd
Type
Standard
Approval Details
Approval Id
0f7264923f6cb5d6
Product Name
LYRICA CR pregabalin 330mg modified release tablet bottle
Artg Id
330343
Artg Name
LYRICA CR pregabalin 330 mg modified release tablet bottle
Sponsor
Viatris Pty Ltd
Company Detail Path
/organization/viatris-pty-ltd
Artg Date
2021-03-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0f7264923f6cb5d6
Type
Standard
Back to TGA Approvals
